hunger glp 1 Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation By helping regulate blood sugar GLP-1 Appetite Suppressant Weight Loss

Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial

May help reduce muscle breakdown Often used in clinical settings for muscle preservation Typical dose: about 3 grams per day Fiber and probiotics GLP-1 medications commonly cause gastrointestinal symptoms

As the activin receptor, the receptor for myostatin, transmits the signals of multiple ligands

Obesity is not a moral failure

Figure 2 Risk of chronic kidney disease (CKD) progression, frequency of visits, and referral to nephrology according to estimated glomerular filtration rate (GFR) and albuminuria

DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited